{"id":3067,"date":"2026-03-04T13:45:54","date_gmt":"2026-03-04T13:45:54","guid":{"rendered":"https:\/\/finzexpert.com\/blog\/stocks-making-the-biggest-moves-premarket-mrna-rost-box-gtlb\/"},"modified":"2026-03-04T13:45:54","modified_gmt":"2026-03-04T13:45:54","slug":"stocks-making-the-biggest-moves-premarket-mrna-rost-box-gtlb","status":"publish","type":"post","link":"https:\/\/finzexpert.com\/blog\/stocks-making-the-biggest-moves-premarket-mrna-rost-box-gtlb\/","title":{"rendered":"Stocks making the biggest moves premarket: MRNA, ROST, BOX, GTLB"},"content":{"rendered":"\n<div>\n<div data-test=\"articleBody-2\" data-analytics=\"RegularArticle-articleBody-5-2\">\n<p><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"ArticleBody-extraData\"><span hidden=\"\" aria-hidden=\"true\" class=\"xyz-data\">Check out the companies making headlines before the bell. Moderna \u2014 The biotechnology firm&#8217;s stock rose nearly 11% after it said it agreed to pay up to $2.25 billion to settle with Biopharma Corporation and Genevant Sciences GmbH a lawsuit over a Covid vaccine patent dispute. Ross Stores \u2014 Shares popped 7% after the off-price retailer reported better-than-expected fourth quarter financial results that showed its sales are rising. The company&#8217;s earnings came in at $2.00 per share, topping analysts&#8217; consensus estimate of $1.9, per FactSet. It also brought in $6.64 billion in revenue, well above the $6.42 billion expected by analysts polled by FactSet. Ross Stores&#8217; sales rose 12.2% to $6.64 billion year over year. CrowdStrike Holdings \u2014 Shares rose roughly 1% after the cybersecurity firm issued strong forward guidance for the first quarter and full year. The company expects to notch earnings of between $1.06 and $1.07 per share excluding some items on revenue of $1.36 &#8211; $1.364 billion in the first quarter. That&#8217;s largely above analysts&#8217; consensus estimates of $1.35 billion in revenue and $1.06 earnings per share, per FactSet. For the full year, CrowdStrike expects to bring in earnings of $4.78 &#8211; $4.90 per share excluding some items versus a consensus of $4.80. Crypto stocks \u2014 Crypto companies&#8217; shares advanced as bitcoin rose nearly 4% to above the $70,000 level for the first time in more than two weeks. Coinbase was up about 5%, while Strategy and Gemini Space Station rose 6% and nearly 3%, respectively. Abercrombie &amp; Fitch \u2014 Shares edged down more than 2% after the apparel retailer reported mixed fourth-quarter results. The company posted earnings of $3.68 per share, excluding some items, versus the $3.57 per share expected by analysts polled by FactSet. Its revenue was in line with analysts&#8217; estimate at $1.67 billion. Abercrombie &amp; Fitch also issued lackluster forward guidance, seeing first-quarter earnings between $1.20 and $1.30 per share, well below analyst expectations of $1.45 per share. The firm also projected lower-than-expected revenue growth. Box \u2014 The company, a content management provider, beat fourth-quarter earnings and revenue expectations and gave strong guidance for the current quarterly period. Box reported earnings of 49 cents per share, on an adjusted basis, and revenue of $306 million for the fourth quarter. Analysts polled by LSEG expected fourth-quarter earnings of 34 cents per share on $304 million in revenue. Shares advanced nearly 5%. GitLab \u2014 The software stock dipped nearly 9% after GitLab&#8217;s fiscal 2027 guidance came out lower than was expected. GitLab. The company guided its fiscal year revenue to between $1.099 billion and $1.118 billion, compared to the $1.12 billion estimate from analysts polled by LSEG. It said it sees fiscal year adjusted earnings ranging between 76 cents and 80 cents per share, falling short of the $1.05 per share estimate, per LSEG. \u2014 CNBC&#8217;s Pia Singh contributed reporting.<\/span><\/span><\/span><span class=\"HighlightShare-hidden\" style=\"top:0;left:0\"\/><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Check out the companies making headlines before the bell. Moderna \u2014 The biotechnology firm&#8217;s stock rose nearly 11% after it said it agreed to pay up to $2.25 billion to settle with Biopharma Corporation and Genevant Sciences GmbH a lawsuit over a Covid vaccine patent dispute. Ross Stores \u2014 Shares popped 7% after the off-price [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3068,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[193,2937,2313,192,194,2591,640,2251,191],"class_list":["post-3067","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-loan","tag-biggest","tag-box","tag-gtlb","tag-making","tag-moves","tag-mrna","tag-premarket","tag-rost","tag-stocks"],"_links":{"self":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/posts\/3067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/comments?post=3067"}],"version-history":[{"count":0,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/posts\/3067\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/media\/3068"}],"wp:attachment":[{"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/media?parent=3067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/categories?post=3067"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finzexpert.com\/blog\/wp-json\/wp\/v2\/tags?post=3067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}